MicroRNA maturation and human disease

Methods in Molecular Biology

Volumn 1095, Issue , 2014, Pages 11-25

  Hesse, Marlen ^a   Arenz, Christoph ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Biomarkers; Dicer; Drosha; Drug targets; miRNAs

Indexed keywords

ANTAGOMIR; BIOLOGICAL MARKER; ENOXACIN; FOMIVIRSEN; MICRORNA; MICRORNA 122; MIRAVIRSEN; STREPTOMYCIN;

BIOGENESIS; CARCINOGENESIS; CLINICAL TRIAL (TOPIC); DIAGNOSTIC PROCEDURE; DOWN REGULATION; DRUG TARGETING; EYE INFLAMMATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CELL CARCINOMA; MATURATION; NEOPLASM; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; UPREGULATION;

ANIMALS; DIAGNOSIS; DISEASE; HUMANS; MICRORNAS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, VIRAL; THERAPEUTICS;

EID: 84934440099     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-703-7_2     Document Type: Review

References (76)

1. Almeida MI, Reis RM, Calin GA (2011) MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res. doi: 10.1016/j.mrfmmm.2011.03.009
2. Stefani G, Slack FJ (2008) Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 9(3):219-230. doi: 10.1038/nrm2347
3. Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5):843-854
4. Ruvkun G, Ambros V, Coulson A, Waterston R, Sulston J, Horvitz HR (1989) Molecular genetics of the Caenorhabditis elegans heterochronic gene lin-14. Genetics 121(3): 501-516
5. Wightman B, Burglin TR, Gatto J, Arasu P, Ruvkun G (1991) Negative regulatory sequences in the lin-14 3?-untranslated region are necessary to generate a temporal switch during Caenorhabditis elegans development. Genes Dev 5(10):1813-1824
6. Olsen PH, Ambros V (1999) The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol 216(2):671-680. doi: 10.1006/dbio.1999.9523
7. Kato M, Slack FJ (2012) Ageing and the small, non-coding RNA world. Ageing Res Rev. doi: 10.1016/j.arr.2012.03.012
8. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR, Ruvkun G (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403(6772): 901-906
9. Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B, Muller P, Spring J, Srinivasan A, Fishman M, Finnerty J, Corbo J, Levine M, Leahy P, Davidson E, Ruvkun G (2000) Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408(6808):86-89. doi: 10.1038/35040556
10. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281-297
11. Siomi H, Siomi MC (2010) Posttranscriptional regulation of microRNA biogenesis in animals. Mol Cell 38(3):323-332. doi: 10.1016/j. molcel.2010.03.013
12. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S, Kim VN (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425(6956): 415-419. doi: 10.1038/nature01957
13. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5(7):522-531. doi: 10.1038/nrg1379
14. Tomari Y, Zamore PD (2005) Perspective: machines for RNAi. Genes Dev 19(5):517-529. doi: 10.1101/gad.1284105
15. Hannon GJ (2002) RNA interference. Nature 418(6894):244-251. doi: 10.1038/418244a.
16. Arenz C (2006) MicroRNAs-future drug targets? Angew Chem Int Ed Engl 45(31):5048-5050
17. Deiters A (2010) Small molecule modifi ers of the microRNA and RNA interference pathway. AAPS J 12(1):51-60. doi: 10.1208/s12248-009-9159-3
18. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR (2005) MicroRNA expression profi les classify human cancers. Nature 435(7043):834-838. doi: 10.1038/nature03702
19. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, Tuschl T (2004) Identifi cation of virus-encoded microRNAs. Science 304(5671):734-736. doi: 10.1126/science. 1096781
20. Cullen BR (2013) MicroRNAs as mediators of viral evasion of the immune system. Nat Immunol 14(3):205-210. doi: 10.1038/ni.2537
21. Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi JT, Braich R, Manoharan M, Soutschek J, Ohler U, Cullen BR (2007) A viral microRNA functions as an orthologue of cellular miR-155. Nature 450(7172):1096-1099. doi: 10.1038/nature05992
22. Zhao Y, Xu H, Yao Y, Smith LP, Kgosana L, Green J, Petherbridge L, Baigent SJ, Nair V (2011) Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek's disease lymphomas. PLoS Pathog 7(2):e1001305. doi: 10.1371/journal.ppat. 1001305
23. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P (2005) Modulation of hepatitis C virus RNA abundance by a liver-specifi c MicroRNA. Science 309(5740):1577-1581. doi: 10.1126/science.1113329
24. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353(17):1793-1801. doi: 10.1056/NEJMoa050995
25. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC (2006) Unique microRNA molecular profi les in lung cancer diagnosis and prognosis. Cancer Cell 9(3):189-198. doi: 10.1016/j.ccr.2006.01.025
26. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65(16):7065-7070. doi: 10.1158/0008-5472. CAN-05-1783
27. Mendell JT, Olson EN (2012) MicroRNAs in stress signaling and human disease. Cell 148(6):1172-1187. doi: 10.1016/j.cell.2012. 02.005
28. Lu M, Zhang Q, Deng M, Miao J, Guo Y, Gao W, Cui Q (2008) An analysis of human microRNA and disease associations. PLoS One 3(10): e3420. doi: 10.1371/journal.pone.0003420
29. Zandberga E, Kozirovskis V, Abols A, Andrejeva D, Purkalne G, Line A (2013) Cellfree microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer. Genes Chromosomes Cancer 52(4):356-369. doi: 10.1002/gcc.22032
30. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105(30):10513-10518. doi: 10.1073/pnas. 0804549105
31. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Zen K, Zhang CY (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18(10):997-1006. doi: 10.1038/cr.2008.282
32. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654-659. doi: 10.1038/ncb1596
33. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, Hristov M, Koppel T, Jahantigh MN, Lutgens E, Wang S, Olson EN, Schober A, Weber C (2009) Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Science Signal 2(100):ra81. doi: 10.1126/scisignal.2000610
34. Mittelbrunn M, Gutierrez-Vazquez C, Villarroya-Beltri C, Gonzalez S, Sanchez-Cabo F, Gonzalez MA, Bernad A, Sanchez-Madrid F (2011) Unidirectional transfer of microRNAloaded exosomes from T cells to antigenpresenting cells. Nat Commun 2:282. doi: 10.1038/ncomms1285
35. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13(4):423-433. doi: 10.1038/ncb2210
36. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, Tait JF, Tewari M (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 108(12): 5003-5008. doi: 10.1073/pnas.1019055108
37. Seggerson K, Tang L, Moss EG (2002) Two genetic circuits repress the Caenorhabditis elegans heterochronic gene lin-28 after translation initiation. Dev Biol 243(2):215-225. doi: 10.1006/dbio.2001.0563
38. Calin GA, Croce CM (2006) MicroRNAcancer connection: the beginning of a new tale. Cancer Res 66(15):7390-7394. doi: 10.1158/0008-5472.CAN-06-0800
39. Liu CG, Calin GA, Volinia S, Croce CM (2008) MicroRNA expression profi ling using microarrays. Nat Protocol 3(4):563-578. doi: 10.1038/nprot.2008.14
40. Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65(14):6029-6033. doi: 10.1158/0008-5472. CAN-05-0137
41. Jiang J, Lee EJ, Schmittgen TD (2006) Increased expression of microRNA-155 in Epstein-Barr virus transformed lymphoblastoid cell lines. Genes Chromosomes Cancer 45(1): 103-106. doi: 10.1002/gcc.20264
42. Wark AW, Lee HJ, Corn RM (2008) Multiplexed detection methods for profi ling microRNA expression in biological samples. Angew Chem Int Ed Engl 47(4):644-652. doi: 10.1002/anie.200702450
43. Meyer SU, Pfaffl MW, Ulbrich SE (2010) Normalization strategies for microRNA profi ling experiments: a 'normal' way to a hidden layer of complexity? Biotechnol Lett 32(12): 1777-1788. doi: 10.1007/s10529-010-0380-z
44. Peltier HJ, Latham GJ (2008) Normalization of microRNA expression levels in quantitative RT-PCR assays: identifi cation of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14(5):844-852. doi: 10.1261/rna.939908
45. Creighton CJ, Reid JG, Gunaratne PH (2009) Expression profi ling of microRNAs by deep sequencing. Brief Bioinform 10(5):490-497. doi: 10.1093/bib/bbp019
46. Bissels U, Wild S, Tomiuk S, Holste A, Hafner M, Tuschl T, Bosio A (2009) Absolute quantifi cation of microRNAs by using a universal reference. RNA 15(12):2375-2384. doi: 10.1261/rna.1754109
47. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6(11):857-866. doi: 10.1038/nrc1997
48. Cole MD, McMahon SB (1999) The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18(19):2916-2924. doi: 10.1038/sj.onc. 1202748
49. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435(7043):839-843
50. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM (2005) A microRNA polycistron as a potential human oncogene. Nature 435(7043):828-833
51. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101(9):2999-3004. doi: 10.1073/pnas.0307323101
52. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM (2006) A microRNA expression signature of human solid tumors defi nes cancer gene targets. Proc Natl Acad Sci USA 103(7): 2257-2261. doi: 10.1073/pnas.0510565103
53. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD, Patel T (2006) Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130(7):2113-2129. doi: 10.1053/j.gastro.2006.02.057
54. Carpenter B, MacKay C, Alnabulsi A, MacKay M, Telfer C, Melvin WT, Murray GI (2006) The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim Biophys Acta 1765(2):85-100. doi: 10.1016/j.bbcan.2005.10.002
55. Karube Y, Tanaka H, Osada H, Tomida S, Tatematsu Y, Yanagisawa K, Yatabe Y, Takamizawa J, Miyoshi S, Mitsudomi T, Takahashi T (2005) Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 96(2):111-115. doi: 10.1111/j.1349-7006.2005.00015.x
56. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64(11):3753-3756. doi: 10.1158/0008-5472.CAN-04-0637
57. Sand M, Skrygan M, Georgas D, Arenz C, Gambichler T, Sand D, Altmeyer P, Bechara FG (2011) Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components Argonaute-1, Argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer. Mol Carcinog. doi: 10.1002/mc.20861
58. Pellegrino L, Jacob J, Roca-Alonso L, Krell J, Castellano L, Frampton AE (2013) Altered expression of the miRNA processing endoribonuclease Dicer has prognostic signifi cance in human cancers. Expert Rev Anticancer Ther 13(1):21-27. doi: 10.1586/era.12.150
59. Jafarnejad SM, Ardekani GS, Ghaffari M, Martinka M, Li G (2012) Sox4-mediated Dicer expression is critical for suppression of melanoma cell invasion. Oncogene. doi: 10.1038/onc.2012.239
60. Shan G, Li Y, Zhang J, Li W, Szulwach KE, Duan R, Faghihi MA, Khalil AM, Lu L, Paroo Z, Chan AW, Shi Z, Liu Q, Wahlestedt C, He C, Jin P (2008) A small molecule enhances RNA interference and promotes microRNA processing. Nat Biotechnol 26(8):933-940. doi: 10.1038/nbt.1481
61. Newman MA, Hammond SM (2010) Emerging paradigms of regulated microRNA processing. Genes Dev 24(11):1086-1092. doi: 10.1101/gad.1919710
62. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature 438(7068):685-689
63. Lindow M, Kauppinen S (2012) Discovering the fi rst microRNA-targeted drug. J Cell Biol 199(3):407-412. doi: 10.1083/jcb.201208082
64. Hu J, Xu Y, Hao J, Wang S, Li C, Meng S (2012) MiR-122 in hepatic function and liver diseases. Protein Cell 3(5):364-371. doi: 10.1007/s13238-012-2036-3
65. Karakatsanis A, Papaconstantinou I, Gazouli M, Lyberopoulou A, Polymeneas G, Voros D (2011) Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic signifi cance. Mol Carcinog. doi: 10.1002/mc.21864
66. Nana-Sinkam SP, Croce CM (2013) Clinical applications for microRNAs in cancer. Clin Pharmacol Ther 93(1):98-104. doi: 10.1038/clpt.2012.192
67. Bonetta L (2009) RNA-based therapeutics: ready for delivery? Cell 136(4):581-584. doi: 10.1016/j.cell.2009.02.010
68. Highleyman L (1998) Fomivirsen. BETA 29: 31
69. Razonable RR (2011) Antiviral drugs for viruses other than human immunodefi ciency virus. Mayo Clin Proc 86(10):1009-1026. doi: 10.4065/mcp.2011.0309
70. Davies BP, Arenz C (2006) A homogenous assay for micro RNA maturation. Angew Chem Int Ed Engl 45(33):5550-5552
71. Davies BP, Arenz C (2008) A fl uorescence probe for assaying micro RNA maturation. Bioorg Med Chem 16(1):49-55
72. Neubacher S, Dojahn CM, Arenz C (2011) A rapid assay for miRNA maturation by using unmodifi ed pre-miRNA. ChemBioChem 12(15):2302-2305. doi: 10.1002/cbic.201100445
73. Bose D, Jayaraj G, Suryawanshi H, Agarwala P, Pore SK, Banerjee R, Maiti S (2012) The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR-21 function by directly targeting its precursor. Angew Chem Int Ed Engl 51(4):1019-1023. doi: 10.1002/anie.201106455
74. Connelly CM, Thomas M, Deiters A (2012) High-throughput luciferase reporter assay for small-molecule inhibitors of microRNA function. J Biomol Screen. doi: 10.1177/108705711
75. Gumireddy K, Young DD, Xiong X, Hogenesch JB, Huang Q, Deiters A (2008) Small-molecule inhibitors of microrna miR-21 function. Angew Chem Int Ed Engl 47(39):7482-7484. doi: 10.1002/anie.200801555
76. Young DD, Connelly CM, Grohmann C, Deiters A (2010) Small molecule modifi ers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma. J Am Chem Soc 132(23):7976-7981. doi: 10.1021/ja910275u